Opening avenue for the targeted treatment of lung cancer using xanthohumol loaded nanostructured lipid carriers

Authors

  • Shubham Singh School of Biosciences and Engineering, Lovely Professional University, Phagwara, Punjab, India https://orcid.org/0009-0004-7069-9643
  • Sangeeta Saxena Department of Biotechnology, Babasaheb Bhimrao Ambedkar University, Lucknow, India https://orcid.org/0000-0001-6412-7631
  • Himani Sharma School of Biosciences and Engineering, Lovely Professional University, Phagwara, Punjab, India https://orcid.org/0009-0002-5725-8072
  • Gaurav Gupta Center of Medical and Bio-allied Health Sciences Research, Ajman University, Ajman, United Arab Emirates; Center for Research Impact & Outcome, Chitkara College of Pharmacy, Chitkara University, Rajpura, Punjab 140401, India https://orcid.org/0000-0001-7941-0229
  • Kamal Dua Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, P.O. Box 123 Broadway, Ultimo, NSW, 2007, Australia. E-mail: Kamal.Dua@uts.edu.au https://orcid.org/0000-0002-7507-1159
  • Sachin Kumar Singh School of Pharmaceutical Sciences, Lovely Professional University, Phagwara-144411, Punjab, India. Tel. +91-9888720835; E-mail: singhsachin23@gmail.com https://orcid.org/0000-0003-3823-6572

DOI:

https://doi.org/10.17179/excli2024-7656

Keywords:

lung cancer, nanostructured lipid carriers, intranasal administration

Published

2024-08-28

How to Cite

Singh, S., Saxena, S., Sharma, H., Gupta, G., Dua, K., & Singh, S. K. (2024). Opening avenue for the targeted treatment of lung cancer using xanthohumol loaded nanostructured lipid carriers . EXCLI Journal, 23, 1068–1070. https://doi.org/10.17179/excli2024-7656

Issue

Section

Letters to the editor

Categories

Most read articles by the same author(s)

1 2 3 4 > >>